Moderna (MRNA)'s 30-day implied volatility (IV30) was 89.1% at the close on November 9, 2026, down from 91.9% the day before, against a 52-week range of 48.2% to 155.4%. Its 20-day historical volatility was 104.2%.
Key numbers
30-day implied volatility (IV30): 89.1%
IV30 52-week range: 48.2% to 155.4% (median 74.2%)